Elevation of oxidative stress in the aorta of genetically hypertensive mice

Mechanisms of Ageing and Development

Volumn 124, Issue 7, 2003, Pages 811-817

  Uddin, Mukarram ^a   Yang, Hong ^a   Shi, MingJian ^a   Polley Mandal, Manorama ^a   Guo, ZhongMao ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Antioxidant enzymes; Hypertensive mice; Oxidative stress

Indexed keywords

ANTIOXIDANT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MALONALDEHYDE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ENZYME ACTIVITY; HYPERTENSION; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0142091095     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(03)00135-0     Document Type: Article

References (41)

1. Beswick R.A., Dorrance A.M., Leite R., Webb R.C. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 38:2001;1107-1111.
2. Brody J.A., Schneider E.L. Diseases and disorders of aging: an hypothesis. J. Chronic Dis. 39:1986;871-876.
3. Chabrashvili T., Tojo A., Onozato M.L., Kitiyakara C., Quinn M.T., Fujita T., Welch W.J., Wilcox C.S. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension. 39:2002;269-274.
4. Djordjevic V.B., Pavlovic D., Pejovic M., Cvetkovic T., Lecic N., Deljanin-Ilic M. Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors. Clin. Nephrol. 47:1997;243-247.
5. Dobrian A.D., Davies M.J., Schriver S.D., Lauterio T.J., Prewitt R.L. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension. 37:2001;554-560.
6. Griendling K.K., Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J. Lab. Clin. Med. 132:1998;9-15.
7. Guo Z.M., Van Remmen H., Yang H., Chen X.L., Mele J., Vijg J., Epstein C.J., Ho Y.-S., Richardson A. Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxLDL-induced apoptosis in mouse aorta cells. Arterioscler. Thromb. Vasc. Biol. 21:2001;1131-1138.
8. Guo Z.M., Yang H., Hamilton M.L., VanRemmen H., Richardson A. Effects of age and food restriction on oxidative DNA damage and antioxidant enzyme activities in the mouse aorta. Mech. Ageing Dev. 122:2001;1771-1786.
9. Harris E.D. Regulation of antioxidant enzymes. J. Nutr. 122:1992;625-626.
10. Jiang Z., Akey J.M., Shi J., Xiong M., Wang Y., Shen Y., Xu X., Chen H., Wu H., Xiao J., Lu D., Huang W., Jin L. A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum. Genet. 109:2001;95-98.
11. John G.W., Valentin J.P. Analysis of the pulmonary hypertensive effects of the isoprostane derivative, 8-iso-PGF2alpha, in the rat. Br. J. Pharmacol. 122:1997;899-905.
12. King C.M., Barnett Y.A. Oxidative stress and human ageing. Biochem. Soc. Trans. 23:1995;375S.
13. Koska J., Syrova D., Blazicek P., Marko M., Grna J.D., Kvetnansky R., Vigas M. Malondialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension. J. Hypertens. 17:1999;529-535.
14. Kristal B., Shurtz-Swirski R., Chezar J., Manaster J., Levy R., Shapiro G., Weissman I., Shasha S.M., Sela S. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. Am. J. Hypertens. 11:1998;921-928.
15. Kumar C.A., Das U.N. Lipid peroxides, anti-oxidants and nitric oxide in patients with pre- eclampsia and essential hypertension. Med. Sci. Monit. 6:2000;901-907.
16. Lacy F., Kailasam M.T., O'Connor D.T., Schmid-Schonbein G.W., Parmer R.J. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension. 36:2000;878-884.
17. Lerman L.O., Nath K.A., Rodriguez-Porcel M., Krier J.D., Schwartz R.S., Napoli C., Romero J.C. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 37:2001;541-546.
18. Lew E.D. High blood pressure, other risk factors and longevity: the insurance viewpoint. Am. J. Med. 55:1973;281-294.
19. McIntyre M., Bohr D.F., Dominiczak A.F. Endothelial function in hypertension: the role of superoxide anion. Hypertension. 34:1999;539-545.
20. Nagaoka A., Kikuchi K., Kawaji H., Matsuo T., Aramaki V. Okamoto K. Spontaneous Hypertension. Its Pathogenesis and Complications. 1972;149-154 Springer, New York.
21. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., Inoue M. Does superoxide underlie the pathogenesis of hypertension. Proc. Natl. Acad. Sci. USA. 88:1991;10045-10048.
22. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., Inoue M. Does superoxide underlie the pathogenesis of hypertension. Proc. Natl. Acad. Sci. USA. 88:1991;10045-10048.
23. Nappi A.J., Vass E. Hydroxyl radical formation resulting from the interaction of nitric oxide and hydrogen peroxide. Biochim. Biophys. Acta. 1380:1998;55-63.
24. Newaz M.A., Nawal N.N. Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR). Clin. Exp. Hypertens. 21:1999;1297-1313.
25. Nishio E., Watanabe Y. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br. J. Pharmacol. 121:1997;665-670.
26. Oliveira L., Stallwood N.A., Crankshaw D.J. Effects of some isoprostanes on the human umbilical artery in vitro. Br. J. Pharmacol. 129:2000;509-514.
27. Parik T., Allikmets K., Teesalu R., Zilmer M. Evidence for oxidative stress in essential hypertension: perspective for antioxidant therapy. J. Cardiovasc. Risk. 3:1996;49-54.
28. Schlager G. Longevity in spontaneously hypertensive mice. Exp. Gerontol. 16:1981;325-330.
29. Schlager G., Sides J. Characterization of hypertensive and hypotensive inbred strains of mice. Lab. Anim. Sci. 47:1997;288-292.
30. Schnackenberg C.G., Welch W.J., Wilcox C.S. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 32:1998;59-64.
31. Suzuki H., Delano F.A., Parks D.A., Jamshidi N., Granger D.N., Ishii H., Suematsu M., Zweifach B.W., Schmid-Schonbein G.W. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc. Natl. Acad. Sci. USA. 95:1998;4754-4759.
32. Swei A., Lacy F., Delano F.A., Schmid-Schonbein G.W. Oxidative stress in the Dahl hypertensive rat. Hypertension. 30:1997;1628-1633.
33. Torrecillas G., Boyano-Adanez M.C., Medina J., Parra T., Griera M., Lopez-Ongil S., Arilla E., Rodriguez-Puyol M., Rodriguez-Puyol D. The role of hydrogen peroxide in the contractile response to angiotensin II. Mol. Pharmacol. 59:2001;104-112.
34. Touyz R.M. Molecular and cellular mechanisms regulating vascular function and structure - implications in the pathogenesis of hypertension. Can. J. Cardiol. 16:2000;1137-1146.
35. Van Remmen H., Salvador C., Epstein C.J., Richardson A. Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse. Arch. Biochem. Biophys. 363:1999;91-97.
36. Vaziri N.D., Ding Y., Ni Z., Gonick H.C. Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy. Kidney Int. 52:1997;1042-1046.
37. Witting P.K., Pettersson K., Ostlund-Lindqvist A.M., Westerlund C., Eriksson A.W., Stocker R. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J. 13:1999;667-675.
38. Yamada M., Omata K., Abe F., Ito S., Abe K. Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia. Immunopharmacology. 44:1999;193-198.
39. Yang H., Shi M.J., Van Remmen H., Chen X., Vijg J., Richardson A., Guo Z.M. Reduction of pressor response to vasoconstrictor agents by overexpression of catalase in mice. Am. J. Hypertens. 16:2003;1-5.
40. Yu B.P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74:1994;139-162.
41. Zalba G., Beaumont F.J., San Jose G., Fortuno A., Fortuno M.A., Etayo J.C., Diez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension. 35:2000;1055-1061.